I am a
Home I AM A Search Login

Papers of the Week

2020 Aug 19


Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-Up.


Bohner A, Topham C, Strunck J, Haynes D, Brazil M, Clements J, Simpson E, Chamberlain W
Cornea. 2020 Aug 19.
PMID: 32826648.


A consecutive case series of patients with dupilumab-associated ocular surface disease (DAOSD) that describes common ocular symptoms and signs, proposes a symptom disease severity grading system, and describes treatment strategies of DAOSD patients was evaluated.